Personalized Interactive Laser Therapy of Port Wine Stain
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00782483
Recruitment Status :
(PI moved out of state.)
Lasers are being used to treat Port Wine Stains (PWS), but the laser doesn't always work. Only about 10% of PWS can be completely cleared. The research team believes that the investigators can improve the response of PWS to laser therapy by using a computer program that the principal investigator of this study (Dr. Shafirstein PhD) has developed. The purpose of this study is to test the validity of this computer program. Personalized Interactive Laser Therapy (PILT) could significantly improve clinical outcomes of laser treatment of PWS.
Condition or disease
Port Wine Stain
Device: ThermoVision A20M Infrared CameraDevice: ScleroPLUSDevice: 3D Digital Camera
Average Laser Setting to be Used to Treat Port Wine Stains as Measured by Mathematical Calculations Based on Imaging and Temperature Analysis of Malformation. [ Time Frame: Three treatments up to one year, whichever is first ]
6 subjects were enrolled but no data was ever collected due to early termination of the study due to the PI's relocation.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
3 Months to 17 Years (Child)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Diagnosed with a PWS
At least one visible PWS measuring greater than or equal to 15 mm in diameter.
Information provided regarding alternative treatment methods, includig no treatment.
Reading, understanding, and signing of an informed consent document.
Children age 7 years or older has read, understood, and signed an assent document.
Agreement to participate in the study.
Agreement to return to at least 1 follow-up evaluation and treatment within 1 year after first treatment.
Zubrod performance status of 0 or 1 at screening.
Inability or unwillingness of subject to participate in the study.
Inability or unwillingness of one parent or legal guardian of the subject to sign written informed consent document.
Subject can not return to at least 1 follow-up visit within 1 year, after the first treatment.